BCAX
Bicara Therapeutics Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$23.17
−0.73%0
Insider buys (3m)
12
Insider sells (3m)
-$3.1M
Net value (3m)
+15.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 14, 2026 | Larson Jennifer · officer: Chief Financial Officer | A-Award | 285,000 | $25 |
| Aug 12, 2026 | Cohlhepp Ryan · director, officer: President and COO | Sale | 18,750 | $28 |
| Aug 12, 2026 | Hyep Ivan · officer: Chief Financial Officer | M-Exempt | 12,500 | $3.79 |
| Aug 12, 2026 | Mazumdar Claire · director, officer: Chief Executive Officer | Sale | 10,000 | $28 |
| Aug 12, 2026 | Mazumdar Claire · director, officer: Chief Executive Officer | M-Exempt | 10,000 | $3.79 |
| Aug 12, 2026 | Hyep Ivan · officer: Chief Financial Officer | Sale | 12,500 | $28 |
| Aug 12, 2026 | Cohlhepp Ryan · director, officer: President and COO | M-Exempt | 18,750 | $3.79 |
| Jul 29, 2026 | Oliger Christy J. · director | A-Award | 38,950 | $27 |
| Jul 29, 2026 | Bender Jeremy · director | A-Award | 38,950 | $27 |
| Jul 14, 2026 | Mazumdar Claire · director, officer: Chief Executive Officer | Sale | 9,972 | $28 |
| Jul 14, 2026 | Mazumdar Claire · director, officer: Chief Executive Officer | Sale | 28 | $30 |
| Jul 14, 2026 | Mazumdar Claire · director, officer: Chief Executive Officer | M-Exempt | 10,000 | $3.79 |
| Jul 10, 2026 | Hyep Ivan · officer: Chief Financial Officer | Sale | 830 | $30 |
| Jul 10, 2026 | Hyep Ivan · officer: Chief Financial Officer | M-Exempt | 908 | $3.79 |
| Jul 10, 2026 | Hyep Ivan · officer: Chief Financial Officer | M-Exempt | 11,592 | $3.79 |
| Jul 10, 2026 | Hyep Ivan · officer: Chief Financial Officer | Sale | 4,413 | $30 |
| Jul 10, 2026 | Hyep Ivan · officer: Chief Financial Officer | Sale | 22,757 | $29 |
| Jul 10, 2026 | Hyep Ivan · officer: Chief Financial Officer | M-Exempt | 12,500 | $3.79 |
| Jul 10, 2026 | Cohlhepp Ryan · director, officer: President and COO | Sale | 536 | $29 |
| Jul 10, 2026 | Cohlhepp Ryan · director, officer: President and COO | Sale | 1,075 | $30 |
| Jul 10, 2026 | Cohlhepp Ryan · director, officer: President and COO | Sale | 4,306 | $30 |
| Jul 10, 2026 | Cohlhepp Ryan · director, officer: President and COO | Sale | 22,833 | $29 |
| Jul 10, 2026 | Cohlhepp Ryan · director, officer: President and COO | M-Exempt | 18,750 | $3.79 |
| Jun 10, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | A-Award | 19,475 | $21 |
| Jun 10, 2026 | Simson Jake · director | A-Award | 19,475 | $21 |
| Jun 10, 2026 | POWELL MICHAEL · director | A-Award | 19,475 | $21 |
| Jun 10, 2026 | Robertson Scott M. · director | A-Award | 19,475 | $21 |
| Jun 10, 2026 | Mazumdar-Shaw Kiran · director | A-Award | 19,475 | $21 |
| Jun 10, 2026 | Haviland Kate · director | A-Award | 19,475 | $21 |
| Jun 10, 2026 | Bowden Christopher · director | A-Award | 19,475 | $21 |
Institutional positioning
13F filings over the trailing two quarters
New 73Increased 126Reduced 84Sold out 9
| Filer | Action | Shares | Filed |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Increased | 7,255,993 | May 15, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 7,255,993 | Aug 14, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Increased | 6,605,780 | May 15, 2026 |
| T. Rowe Price Investment Management, Inc. | Reduced | 6,338,487 | Aug 14, 2026 |
| SIREN, L.L.C. | Increased | 5,802,970 | May 14, 2026 |
| Siren, L.L.C. | Reduced | 5,602,970 | Aug 13, 2026 |
| VESTAL POINT CAPITAL, LP | Increased | 5,425,000 | May 15, 2026 |
| Vestal Point Capital, LP | Reduced | 5,250,000 | Aug 14, 2026 |
| Deep Track Capital, LP | Increased | 4,100,000 | Aug 14, 2026 |
| DEEP TRACK CAPITAL, LP | Increased | 4,062,500 | May 15, 2026 |
| BlackRock, Inc. | Increased | 3,848,090 | Aug 7, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 3,339,218 | May 18, 2026 |
| Jupiter Topco LLC | New Position | 3,171,015 | Aug 14, 2026 |
| RED TREE MANAGEMENT, LLC | Unchanged | 3,170,509 | Apr 22, 2026 |
| Red Tree Management, LLC | Reduced | 3,163,517 | Jul 22, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 14, 2026